English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51636464    線上人數 :  873
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"wu cheng chung"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 21-30 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2012 Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection Chen, Li-Tzong; Chen, Miin-Fu; Li, Lung-An; Lee, Po-Huang; Jeng, Long-Bin; Lin, Deng-Yn; Wu, Cheng-Chung; Mok, King-Tong; Chen, Chao-Long; Lee, Wei-Chen; Chau, Gar-Yang; Chen, Yaw-Sen; Lui, Wing-Yui; Hsiao, Chin-Fu; Whang-Peng, Jacqueline; Chen, Pei-Jer; 陳培哲; 李伯皇
國立臺灣大學 2012 A shRNA Functional Screen Reveals Nme6 and Nme7 Are Crucial for Embryonic Stem Cell Renewal Wang, Chia-Hui; Ma, Nianhan; Lin, Yu-Tsen; Wu, Cheng-Chung; Hsiao, Michael; Lu, Frank Leigh; Yu, Ching-Chia; Chen, Shao-Yin; Lu, Jean; 呂立
國立成功大學 2011-02-20 High resolution melting analysis for the detection of SLC25A13 gene mutations in Taiwan Lin, Jing-Ting; Hsiao, Kwang-Jen; Chen, Chiung-Yu; Wu, Cheng-Chung; Lin, Shio-Jean; Chou, Yen-Yin; Shiesh, Shu-Chu
國立高雄第一科技大學 2010-10-25 房屋貸款違約與提前清償風險因素之研究 吳政仲; Wu Cheng-Chung
國立高雄第一科技大學 2009.08 Hedging with derivatives by Taiwanese listed non-financial companies Hsu, Shuofen;Ko, Po-Sheng;Wu, Cheng-Chung;Cheng, Shuen-Ren;Chen, Yung-Sheng
國立成功大學 2009-05 Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer
國立臺灣大學 2009 Heparanase Inhibitor Pi-88 as Adjuvant Therapy for Hepatocellular Carcinoma after Curative Resection: A Randomized Phase Ii Trial for Safety and Optimal Dosage 劉俊人; 李伯皇; 胡瑞恆; 吳誠中; 鄭隆賓; 林炳文; 莫景棠; 葉宏仁; 何明志; 楊勝舜; 陳培哲; LIU, CHUN-JEN; LEE, PO-HUANG; HU, REY-HENG; WU, CHENG-CHUNG; JENG, LONG-BIN; LIN, PIN-WEN; MOK, KING-TONG; YEH, HONG-ZEN; HO, MING-CHIH; YANG, SHENG-SHUN; CHEN, PEI-JER
國立臺灣大學 2009 Factors Related to Clinical Hypothyroid Severity in Thyroid Cancer Patients after Thyroid Hormone Withdrawal 吳允升; 林時逸; 許惠恒; 宋育民; 林彥宏; 吳誠中; 張文道; WU, VIN-CENT; LIN, SHIH-YI; SHEU, WAYNE HUEY-HERNG; SONG, YUH-MIN; LIN, YEN-HUNG; WU, CHENG-CHUNG; CHANG, WEN-DAU
東海大學 2008-07 HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade. 黃光裕; Kuo, Chan-Yen; Wu, Cheng-Chung; Hsu, Shih-Lan; Hwang, Guang-Yuh
東海大學 2008-04 Effects of hepatitis B virus X protein (HBx) on cell-growth inhibition in a CCL13-HBx stable cell line. 黃光裕; Kuo, Chan-Yen; Wang, Jing-Chyi; Wu, Cheng-Chung; Hsu, Shih-Lan; Hwang, Guang-Yuh

顯示項目 21-30 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目